Zambon's Corporate Licensing Department is always actively looking for projects/products, also through synergistic collaboration, to implement the company's pipeline as well as partners to fully exploit Zambon project portfolio. Zambon's current strategy is to develop a portfolio of products that extends beyond an exclusive focus on ethical drugs, with an integrated product line ranging from classical ethical drugs to supplements and self-medication products, providing a complete disease management system. Main target diseases are all these illnesses that are primarily diagnosed by GPs or chronic pathologies that are followed by the GPs.
Zambon's Corporate Licensing is looking for NCEs, new patented formulations and products for the treatment of:
* Woman's Care
* Pain relief
* GastroIntestinal Business relationship sought
* Co-development, co-commercialisation, partnerships